4
MARKET OVERVIEW
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN ASIA PACIFIC HEALTHCARE INDUSTRY
5.2.4
TRENDS IN ASIA PACIFIC MEDICAL DEVICE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE OF KEY PLAYERS, BY END-USE INDUSTRY, 2023–2025
5.6.2
AVERAGE SELLING PRICE TREND, BY TYPE, 2023–2025
5.6.3
AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025
5.6.4
AVERAGE SELLING PRICE TREND, BY INSERTION METHOD, 2023–2025
5.7.1
IMPORT SCENARIO (HS CODE 9018.39)
5.7.2
EXPORT SCENARIO (HS CODE 9018.39)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFF – ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES
5.12.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
FLOW GENERATION MECHANISMS
6.1.2
FLOW CONTROL MECHANISMS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.3
FEEDING TUBE REPLACEMENT TECHNOLOGY
6.2.3.1
ELECTROMAGNETIC SENSOR-BASED SYSTEMS
6.2.3.2
CAMERA-BASED SYSTEMS
6.2.3.3
IMPEDENCE SENSOR-BASED SYSTEMS
6.3
ADJACENT TECHNOLOGIES
6.3.1
NUTRITIONAL FORMULA DEVELOPMENT
6.3.2
WIRELESS CONNECTIVITY
6.3.3
MODEL-BASED INFUSION PUMPS
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON THE ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES IN ENTERAL FEEDING DEVICES
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
REGIONAL REIMBURSEMENT ANALYSIS
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2032 – IN VALUE, USD MILLION & VOLUME UNITS)
9.2
ENTERAL FEEDING DEVICES
9.2.1
NASAL FEEDING TUBES
9.2.1.1
NASOGASTRIC (NG) TUBES
9.2.1.2
NASOJEJUNAL (NJ) TUBES
9.2.1.3
NASODUODENAL (ND) TUBES
9.2.3
GASTRIC/GASTROSTOMY TUBES (G-TUBES)
9.2.3.1
STANDARD GASTROSTOMY TUBES
9.2.3.2
LOW-PROFILE GASTROSTOMY TUBES
9.2.4
JEJUNOSTOMY TUBES (J-TUBES)
9.2.4.1
STANDARD JEJUNOSTOMY TUBES
9.2.4.2
LOW-PROFILE JEJUNOSTOMY TUBES
9.2.5
GASTROTOMY-JEJUNOSTOMY TUBES (GJ-TUBES)
9.2.5.1
STANDARD GASTROTOMY-JEJUNOSTOMY TUBES
9.2.5.2
LOW PROFILE GASTROTOMY-JEJUNOSTOMY TUBES
9.3
ENTERAL FEEDING PUMPS
9.3.1
PORTABLE ENTERAL FEEDING PUMPS
9.3.2
STATIONARY ENTERAL FEEDING PUMPS
9.6
CONSUMABLES & ACCESSORIES
9.6.1
CONNECTORS/CAPS/ADAPTERS
9.6.3
TUBE STABILIZERS / FIXATION DEVICES
9.6.4
FLUSH / IRRIGATION ACCESSORIES
NOTE: OTHER ACCESSORIES INCLUDE SLEEVES, COVERS, IV POUCHES, AND NUTRITIONAL STRAWS, AMONG OTHERS.
10
ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET, BY INSERTION METHOD (MARKET SIZE & FORECAST TO 2032 – IN VALUE, USD MILLION)
10.2
TRANSNASAL, TRANSORAL, AND PERCUTANEOUS ENDOSCOPIC INSERTION (PEG/PEJ)
10.3
RADIOLOGICAL INSERTION (RIG / RIJ)
11
ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP (MARKET SIZE & FORECAST TO 2032 – IN VALUE, USD MILLION)
12
ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2032 – IN VALUE, USD MILLION)
12.2.1
HEAD & NECK CANCERS
12.2.2
STOMACH & GASTROINTESTINAL CANCERS
12.2.6
OTHER CANCER TYPES
12.3
GASTROINTESTINAL DISEASES
12.4
NEUROLOGICAL DISORDERS
12.5
RESPIRATORY DISORDERS
12.6
CARDIOVASCULAR DISORDERS
NOTE: OTHER CANCER TYPES INCLUDE LUNGS, BREAST, OVARIAN, PROSTATE, BLOOD, AND RENAL CANCERS, AMONG OTHERS
NOTE: OTHER APPLICATIONS INCLUDE DIABETES, RENAL DISORDERS, LIVER DISEASES, AND PSYCHIATRIC DISORDERS, AMONG OTHERS.
13
ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2032 – IN VALUE, USD MILLION)
13.4
AMBULATORY CARE SETTINGS
NOTE: OTHER END USERS INCLUDE SPECIALTY CLINICS, LONG-TERM CARE FACILITIES, AND NURSING HOMES, AMONG OTHERS.
14
ASIA PACIFIC ENTERAL FEEDING DEVICES MARKET, BY COUNTRY (MARKET SIZE & FORECAST TO 2032 – IN VALUE, USD MILLION & VOLUME UNITS)
14.4.1
VOLUME ANALYSIS, BY TYPE, 2023–2032 (THOUSAND UNITS)
14.4.9
REST OF ASIA PACIFIC
NOTE: REST OF ASIA PACIFIC INCLUDES BANGLADESH, BHUTAN, NEPAL, SRI LANKA, TAIWAN, CAMBODIA, AND INDONESIA.
15.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
15.3
AISA PACIFIC REVENUE SHARE ANALYSIS
15.4
ASIA PACIFIC MARKET SHARE ANALYSIS
15.5.1
FRESENIUS KABI – (FREKA)
15.5.2
CARDINAL HEALTH – (KANGAROO)
15.5.3
AVANOS MEDICAL – (CORFLO)
15.5.4
BECTON, DICKINSON AND COMPANY – (BD ENTERAL SYRINGES AND ACCESSORIES)
15.5.5
B. BRAUN – (INTROFLO / NUTRICOMP)
15.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
15.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
15.6.5.1
COMPANY FOOTPRINT
15.6.5.2
COUNTRY FOOTPRINT
15.6.5.4
INSERTION METHOD FOOTPRINT
15.6.5.5
AGE GROUP FOOTPRINT
15.6.5.6
APPLICATION FOOTPRINT
15.7
COMPANY EVALUATION MATRIX: STARTUPS/SME’S,
15.7.1
PROGRESSIVE COMPANIES
15.7.2
RESPONSIVE COMPANIES
15.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
15.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
15.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
15.8
COMPANY VALUATION AND FINANCIAL MATRICS
15.9
COMPETITIVE SCENARIO
15.9.4
OTHER DEVELOPMENTS
16.1.2
CARDINAL HEALTH, INC.
16.1.4
AVANOS MEDICAL, INC
16.1.6
BECTON, DICKINSON AND COMPANY
16.1.7
B. BRAUN MELSUNGEN AG
16.1.8
CONMED CORPORATION
16.1.11
BOSTON SCIENTIFIC CORPORATION
16.1.12
BAXTER INTERNATIONAL INC.
16.1.14
TERUMO CORPORATION
16.1.15
WEIGAO MEIDCAL INTERNATIONAL CO., LTD
16.1.18
APPLIED MEDICAL TECHNOLOGY, INC
16.1.19
AMSINO INTERNATIONAL, INC.
16.2.1
MEDLINE INDUSTRIES, INC.
16.2.3
DYNAREX CORPORATION
16.2.5
JIANGSU KANGJIN MEDICAL INSTRUMENT CO., LTD
17.1.1.1
KEY DATA FROM SECONDARY SOURCES
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
17.1.2.2
KEY PRIMARY PARTICIPANTS
17.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
17.1.2.4
KEY INDUSTRY INSIGHTS
17.2
MARKET SIZE ESTIMATION
17.2.1
BOTTOM-UP APPROACH
17.2.3
BASE NUMBER CALCULATION
17.3
MARKET FORECAST APPROACH
17.6
RESEARCH ASSUMPTIONS
17.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
18.3
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.4
CUSTOMIZATION OPTIONS
18.4.1
COUNTRY-LEVEL MARKET SHARE ANALYSIS
18.4.2
COMPANY INFORMATION
18.4.4
COUNTRY-LEVEL VOLUME ANALYSIS
18.4.5
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST
18.4.6
BY TYPE ASIA PACIFIC MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
Growth opportunities and latent adjacency in Asia Pacific Enteral